FDA Inspection 1005522 — Zogg, Donald L., M.D., Clinical Investigator

Zogg, Donald L., M.D., Clinical Investigator — FEI 3013186130

The FDA completed an inspection of Zogg, Donald L., M.D., Clinical Investigator on Mar 1, 2017 in Saint Paul, MN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 1, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Saint Paul, MN (United States)

Additional Details

Clinical Investigator (CI)